|
1
|
Gotwals P, Cameron S, Cipolletta D,
Cremasco V, Crystal A, Hewes B, Mueller B, Quaratino S,
Sabatos-Peyton C, Petruzzelli L, et al: Prospects for combining
targeted and conventional cancer therapy with immunotherapy. Nat
Rev Cancer. 17:286–301. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tan TC, Neilan TG, Francis S, Plana JC and
Scherrer-Crosbie M: Anthracycline-induced cardiomyopathy in adults.
Compr Physiol. 5:1517–1540. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Octavia Y, Tocchetti CG, Gabrielson KL,
Janssens S, Crijns HJ and Moens AL: Doxorubicin-induced
cardiomyopathy: From molecular mechanisms to therapeutic
strategies. J Mol Cell Cardiol. 52:1213–1225. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu
YL, Liu LF and Yeh ET: Identification of the molecular basis of
doxorubicin-induced cardiotoxicity. Nat Med. 18:1639–1642.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Li DL, Wang ZV, Ding G, Tan W, Luo X,
Criollo A, Xie M, Jiang N, May H, Kyrychenko V, et al: Doxorubicin
blocks cardiomyocyte autophagic flux by inhibiting lysosome
acidification. Circulation. 133:1668–1687. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ali BH and Blunden G: Pharmacological and
toxicological properties of Nigella sativa. Phytother Res.
17:299–305. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Shaterzadeh-Yazdi H, Noorbakhsh MF, Hayati
F, Samarghandian S and Farkhondeh T: Immunomodulatory and
anti-inflammatory effects of thymoquinone. Cardiovasc Hematol
Disord Drug Targets. 18:52–60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nagi MN and Mansour MA: Protective effect
of thymoquinone against doxorubicin-induced cardiotoxicity in rats:
A possible mechanism of protection. Pharmacol Res. 41:283–289.
2000.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Karabulut D, Ozturk E, Kaymak E, Akin AT
and Yakan B: Thymoquinone attenuates doxorubicin-cardiotoxicity in
rats. J Biochem Mol Toxicol. 35(e22618)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pehlivan DY, Durdagi G, Oyar EO, Akyol S
and Ozbek M: The effects of melatonin and thymoquinone on
doxorubicin-induced cardiotoxicity in rats. Bratisl Lek Listy.
121:753–759. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Curigliano G, Cardinale D, Suter T,
Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, Goldhirsch
A, Cipolla C and Roila F: ESMO Guidelines Working Group.
Cardiovascular toxicity induced by chemotherapy, targeted agents
and radiotherapy: ESMO clinical practice guidelines. Ann Oncol. 23
(Suppl 7):vii155–166. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Robertson ID, Naprasnik A and Morrow D:
The sources of pesticide contamination in Queensland livestock.
Aust Vet J. 67:152–153. 1990.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wenningmann N, Knapp M, Ande A, Vaidya TR
and Ait-Oudhia S: Insights into doxorubicin-induced cardiotoxicity:
Molecular mechanisms, preventive strategies, and early monitoring.
Mol Pharmacol. 96:219–232. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Al-Malky HS, Al Harthi SE and Osman AM:
Major obstacles to doxorubicin therapy: Cardiotoxicity and drug
resistance. J Oncol Pharm Pract. 26:434–444. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ali MY, Akter Z, Mei Z, Zheng M, Tania M
and Khan MA: Thymoquinone in autoimmune diseases: Therapeutic
potential and molecular mechanisms. Biomed Pharmacother.
134(111157)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gholamnezhad Z, Havakhah S and Boskabady
MH: Preclinical and clinical effects of Nigella sativa and
its constituent, thymoquinone: A review. J Ethnopharmacol.
190:372–386. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Imran M, Rauf A, Khan IA, Shahbaz M,
Qaisrani TB, Fatmawati S, Abu-Izneid T, Imran A, Rahman KU and
Gondal TA: Thymoquinone: A novel strategy to combat cancer: A
review. Biomed Pharmacother. 106:390–402. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Isaev NK, Chetverikov NS, Stelmashook EV,
Genrikhs EE, Khaspekov LG and Illarioshkin SN: Thymoquinone as a
potential neuroprotector in acute and chronic forms of cerebral
pathology. Biochemistry (Mosc). 85:167–176. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Abdel-Daim MM, Abo El-Ela FI, Alshahrani
FK, Bin-Jumah M, Al-Zharani M, Almutairi B, Alyousif MS, Bungau S,
Aleya L and Alkahtani S: Protective effects of thymoquinone against
acrylamide-induced liver, kidney and brain oxidative damage in
rats. Environ Sci Pollut Res Int. 27:37709–37717. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nili-Ahmadabadi A, Alibolandi P, Ranjbar
A, Mousavi L, Nili-Ahmadabadi H, Larki-Harchegani A,
Ahmadimoghaddam D and Omidifar N: Thymoquinone attenuates
hepatotoxicity and oxidative damage caused by diazinon: An in vivo
study. Res Pharm Sci. 13:500–508. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Alam MF, Khan G, Safhi MM, Alshahrani S,
Siddiqui R, Sivagurunathan Moni S and Anwer T: Thymoquinone
ameliorates doxorubicin-induced cardiotoxicity in swiss albino mice
by modulating oxidative damage and cellular inflammation. Cardiol
Res Pract. 2018(1483041)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Öztürk E, Kaymak E, Akin A, Karabulut D,
Ünsal HM and Yakan B: Thymoquinone is a protective agent that
reduces the negative effects of doxorubicin in rat testis. Hum Exp
Toxicol. 39:1364–1373. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Timm KN and Tyler DJ: The role of AMPK
activation for cardioprotection in doxorubicin-induced
cardiotoxicity. Cardiovasc Drugs Ther. 34:255–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dirks-Naylor AJ: The role of autophagy in
doxorubicin-induced cardiotoxicity. Life Sci. 93:913–916.
2013.PubMed/NCBI
|
|
25
|
Shabalala S, Muller CJF, Louw J and
Johnson R: Polyphenols, autophagy and doxorubicin-induced
cardiotoxicity. Life Sci. 180:160–170. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ma Y, Yang L, Ma J, Lu L, Wang X, Ren J
and Yang J: Rutin attenuates doxorubicin-induced cardiotoxicity via
regulating autophagy and apoptosis. Biochim Biophys Acta Mol Basis
Dis. 1863:1904–1911. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xu ZM, Li CB, Liu QL, Li P and Yang H:
Ginsenoside Rg1 prevents doxorubicin-induced cardiotoxicity through
the inhibition of autophagy and endoplasmic reticulum stress in
mice. Int J Mol Sci. 19(3658)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Codogno P, Mehrpour M and Proikas-Cezanne
T: Canonical and non-canonical autophagy: Variations on a common
theme of self-eating? Nat Rev Mol Cell Biol. 13:7–12.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Khan N and Sultana S: Inhibition of two
stage renal carcinogenesis, oxidative damage and hyperproliferative
response by Nigella sativa. Eur J Cancer Prev. 14:159–168.
2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vance SH, Benghuzzi H, Wilson-Simpson F
and Tucci M: Thymoquinone supplementation and its effect on kidney
tubule epithelial cells in vitro. Biomed Sci Instrum. 44:477–482.
2008.PubMed/NCBI
|
|
31
|
Mu GG, Zhang LL, Li HY, Liao Y and Yu HG:
Thymoquinone pretreatment overcomes the insensitivity and
potentiates the antitumor effect of gemcitabine through abrogation
of notch1, PI3K/Akt/mTOR regulated signaling pathways in pancreatic
cancer. Dig Dis Sci. 60:1067–1080. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Qadri SM, Mahmud H, Föller M and Lang F:
Thymoquinone-induced suicidal erythrocyte death. Food Chem Toxicol.
47:1545–1549. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Khader M, Bresgen N and Eckl P: In vitro
toxicological properties of thymoquinone. Food Chem Toxicol.
47:129–133. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dollah MA, Parhizkar S, Latiff LA and Bin
Hassan MH: Toxicity effect of Nigella sativa on the liver
function of rats. Adv Pharm Bull. 3:97–102. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Abukhader M: The effect of route of
administration in thymoquinone toxicity in male and female rats.
Indian J Pharm Sci. 74(195)2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gali-Muhtasib H, Kuester D, Mawrin C,
Bajbouj K, Diestel A, Ocker M, Habold C, Foltzer-Jourdainne C,
Schoenfeld P, Peters B, et al: Thymoquinone triggers inactivation
of the stress response pathway sensor CHEK1 and contributes to
apoptosis in colorectal cancer cells. Cancer Res. 68:5609–5618.
2008.PubMed/NCBI View Article : Google Scholar
|
